Difference between revisions of "LncRNAWiki:Bladder-cancer"
| Line 1: | Line 1: | ||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
| − | |||
!width="50"|Name | !width="50"|Name | ||
!width="50"|Transcript ID | !width="50"|Transcript ID | ||
!width="50"|Alias | !width="50"|Alias | ||
!width="50"|Description | !width="50"|Description | ||
| − | !width="50"| | + | !width="50"|Disease |
|- | |- | ||
| − | |||
|''MALAT1'' | |''MALAT1'' | ||
|[[ENST00000534336.1]] | |[[ENST00000534336.1]] | ||
|HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47", "nuclear enriched abundant transcript 2", "nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562 | |HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47", "nuclear enriched abundant transcript 2", "nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562 | ||
|metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | |metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | ||
| − | | | + | |bladder cancer, lung adenocarcinoma |
|- | |- | ||
| − | |||
|''TUG1'' | |''TUG1'' | ||
|[[NONHSAT084827]] | |[[NONHSAT084827]] | ||
|ENSG00000253352 | |ENSG00000253352 | ||
|taurine up-regulated gene 1 | |taurine up-regulated gene 1 | ||
| − | | | + | |bladder cancer |
|- | |- | ||
| − | |||
|''BLACAT1'' | |''BLACAT1'' | ||
|[[BLACAT1]] | |[[BLACAT1]] | ||
| Line 29: | Line 25: | ||
|bladder cancer | |bladder cancer | ||
|- | |- | ||
| − | |||
|''ZEB2-AS1'' | |''ZEB2-AS1'' | ||
|[[NONHSAT074775]] | |[[NONHSAT074775]] | ||
| Line 36: | Line 31: | ||
|bladder cancer | |bladder cancer | ||
|- | |- | ||
| − | |||
|''AATBC'' | |''AATBC'' | ||
|[[AATBC]] | |[[AATBC]] | ||
| Line 43: | Line 37: | ||
|bladder cancer | |bladder cancer | ||
|- | |- | ||
| − | |||
|''MDC1-AS1'' | |''MDC1-AS1'' | ||
|[[MDC1-AS1]] | |[[MDC1-AS1]] | ||
| Line 50: | Line 43: | ||
| bladder cancer | | bladder cancer | ||
|- | |- | ||
| − | |||
|''H19'' | |''H19'' | ||
|[[NONHSAT017465]] | |[[NONHSAT017465]] | ||
| Line 57: | Line 49: | ||
|"bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor" | |"bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor" | ||
|- | |- | ||
| − | |||
|''MEG3'' | |''MEG3'' | ||
|[[NONHSAT039745]] | |[[NONHSAT039745]] | ||
|Gtl2, ENSG00000214548 | |Gtl2, ENSG00000214548 | ||
|maternally expressed 3 (non-protein coding) | |maternally expressed 3 (non-protein coding) | ||
| − | | | + | |bladder cancer |
|- | |- | ||
| − | |||
|''XIST'' | |''XIST'' | ||
|[[NONHSAT137541]] | |[[NONHSAT137541]] | ||
|ENSG00000229807 | |ENSG00000229807 | ||
|X inactive-specific transcript | |X inactive-specific transcript | ||
| − | | | + | |bladder cancer |
|- | |- | ||
| − | |||
|''SNHG16'' | |''SNHG16'' | ||
|[[NONHSAT056039]] | |[[NONHSAT056039]] | ||
| Line 78: | Line 67: | ||
|bladder cancer, colorectal cancer | |bladder cancer, colorectal cancer | ||
|- | |- | ||
| − | |||
|''UCA1'' | |''UCA1'' | ||
|[[lnc-OR10H5-1:1]] | |[[lnc-OR10H5-1:1]] | ||
|UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049 | |UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049 | ||
|urothelial cancer associated 1 (non-protein coding) | |urothelial cancer associated 1 (non-protein coding) | ||
| − | | | + | |bladder cancer |
|- | |- | ||
| − | |||
|''DRAIC'' | |''DRAIC'' | ||
|[[DRAIC]] | |[[DRAIC]] | ||
| Line 92: | Line 79: | ||
|prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma | |prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma | ||
|- | |- | ||
| − | |||
|''G2E3-AS1'' | |''G2E3-AS1'' | ||
|[[G2E3-AS1]] | |[[G2E3-AS1]] | ||
| Line 99: | Line 85: | ||
|Bladder cancer | |Bladder cancer | ||
|- | |- | ||
| − | |||
|''SNHG26'' | |''SNHG26'' | ||
|[[SNHG26]] | |[[SNHG26]] | ||
Latest revision as of 04:06, 30 June 2017
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| MALAT1 | ENST00000534336.1 | HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47", "nuclear enriched abundant transcript 2", "nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | bladder cancer, lung adenocarcinoma |
| TUG1 | NONHSAT084827 | ENSG00000253352 | taurine up-regulated gene 1 | bladder cancer |
| BLACAT1 | BLACAT1 | linc-UBC1,LINC00912, onco-lncRNA-30 | bladder cancer associated transcript 1 (non-protein coding) | bladder cancer |
| ZEB2-AS1 | NONHSAT074775 | Zeb2NAT, ENSG00000238057 | Zeb2 natural antisense transcript | bladder cancer |
| AATBC | AATBC | N/A | apoptosis associated transcript in bladder cancer | bladder cancer |
| MDC1-AS1 | MDC1-AS1 | MDC1-AS | MDC1 antisense RNA 1 | bladder cancer |
| H19 | NONHSAT017465 | Q96MK8,ENSG00000130600 | "H19, imprinted maternally expressed transcript (non-protein coding)" | "bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor" |
| MEG3 | NONHSAT039745 | Gtl2, ENSG00000214548 | maternally expressed 3 (non-protein coding) | bladder cancer |
| XIST | NONHSAT137541 | ENSG00000229807 | X inactive-specific transcript | bladder cancer |
| SNHG16 | NONHSAT056039 | ncRAN | small nucleolar RNA host gene 16 | bladder cancer, colorectal cancer |
| UCA1 | lnc-OR10H5-1:1 | UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049 | urothelial cancer associated 1 (non-protein coding) | bladder cancer |
| DRAIC | DRAIC | N/A | "downregulated RNA in cancer, inhibitor of cell invasion and migration" | prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma |
| G2E3-AS1 | G2E3-AS1 | CAT1647 | G2E3 antisense RNA 1 | Bladder cancer |
| SNHG26 | SNHG26 | AC005682.5 | small nucleolar RNA host gene 26 | Bladder urothelial carcinoma |
